Our research is clinically focused, ethically appropriate and fiscally responsible.
Our staff has many years experience in the area of blood coagulation.
One of our primary programs develops novel cancer treatments and tumor markers.
We’re a source of information for health care professionals, patients and their families.
One of the major research programs at the Florida Hospital Center for Thrombosis Research focuses on the relationship between the coagulation system and the growth and spread of cancer. Our scientists have published many papers in this area since the program at Florida Hospital began in 1994. The goal of this program is to elucidate the complex relationship between the coagulation system and malignant disease with the aim of developing novel cancer treatments and tumor markers.
The Florida Hospital Center for Thrombosis Research also has a research program that is focused on the mechanisms of thrombosis, antibody-mediated platelet activation, and the detection of hypercoagulable states. This program aims to develop new methods for thrombosis risk assessment in patients with cancer, cardiovascular disease and other disorders.
HELP US SAVE LIVES. TODAY, TOMORROW, AND IN THE FUTURE. Finding the cure to the most dreaded diseases of our generation greatly depends on philanthropic support. We are seeking to build partnerships with individuals, businesses, and not-for profit foundations who have a passion for their communities and are interested in changing lives through medical research.
Help us get closer to the answers by teaming up with us as we pursue research in the areas that are most critical in today’s healthcare!
For more information on how to give, please contact John Francis at 407-303-2444 or e-mail at John.Francis@flhosp.org
Or visit the Florida Hospital Foundation’s website: www.floridahospitalfoundation.org
Cardiovascular Research The central focus of the Cardiovascular Research Program is the study of the blood coagulation system, and the way it is involved with diseases such as heart attacks and strokes. The goal of the program is to develop new diagnostic tests and novel drug therapies. Our ultimate objective is to reduce the number of patients affected by these dreaded illnesses not only in the United States, but globally.
Cancer Research The focus of our Cancer Research Program is to study the relationship of the blood clotting system to the way cancer spreads in the body, with the ultimate goal of developing new approaches to cancer therapy for adults and children. The specific areas our research is currently focusing on include: ovarian cancer, breast cancer, and brain cancer, with the capability of expanding into other areas in the future./p>
Lupus Research Program Patients with Lupus produce a variety of antibodies against their own proteins (so-called auto-antibodies). These individuals suffer from premature atherosclerosis and are at higher risk of developing blood clots. The goal of our research program is to determine how auto-antibodies against clotting proteins increase the risk of thrombosis in this patient group.